Last reviewed · How we verify
Onychomycosis due to dermatophyte
Approved treatments
- Jublia · Bausch Health
Jublia works by inhibiting the fungal enzyme lanosterol 14α-demethylase, which is essential for the production of ergosterol, a critical component of fungal cell membranes. - Grifulvin V · Johnson And Johnson
- FULVICIN P/G 330 · CHARTWELL RX
- GRISEOFULVIN · COSETTE
- GRISACTIN ULTRA · WYETH AYERST
- Monistat · Johnson & Johnson (Janssen)
- Loprox · Bausch Health
- GRIFULVIN V · JOHNSON AND JOHNSON
- Penlac · 9305-9954 Quebec Inc
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Onychomycosis due to dermatophyte patent landscape — cliff calendar, originator estates, attackable patents
- Onychomycosis due to dermatophyte treatment landscape brief
- Onychomycosis due to dermatophyte treatment updates RSS
Frequently asked questions about Onychomycosis due to dermatophyte
What drugs treat Onychomycosis due to dermatophyte?
Tracked treatments include Jublia, Grifulvin V, FULVICIN P/G 330, GRISEOFULVIN, GRISACTIN ULTRA, Monistat, Loprox, GRIFULVIN V.
What is the treatment for Onychomycosis due to dermatophyte?
Standard treatment for Onychomycosis due to dermatophyte includes Jublia, Grifulvin V, FULVICIN P/G 330, GRISEOFULVIN, GRISACTIN ULTRA. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Onychomycosis due to dermatophyte patent cliff · Onychomycosis due to dermatophyte CI report
- Treatment: Jublia · Bausch Health
- Treatment: Grifulvin V · Johnson And Johnson
- Treatment: FULVICIN P/G 330 · CHARTWELL RX
- Treatment: GRISEOFULVIN · COSETTE
- Treatment: GRISACTIN ULTRA · WYETH AYERST
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing